Ask Me Anything: Drugs to Watch 2025
Fill out the form below and we'll send your colleague an invitation to the "Ask Me Anything: Drugs to Watch 2025" event.
Cell and gene therapy is transforming modern medicine, offering innovative treatments for genetic disorders, cancers and rare diseases. But what’s next in this rapidly evolving field? What challenges remain and which emerging therapies are poised to make the biggest impact?
Join us for an exclusive Ask Me Anything session with Mike Ward, Head of Thought Leadership at Clarivate, as we explore the latest advancements in cell and gene therapy. Leveraging insights from Clarivate’s Drugs to Watch 2025 report, we’ll discuss the therapies set to reshape healthcare and the industry trends driving innovation.
On March 12, Mike will explore topics such as:
- The most promising gene and cell therapies on the horizon
- Key drugs from Drugs to Watch 2025 and their impact
- Regulatory trends and market access challenges
- The role of AI and real-world data in advancing gene therapy
- The future of precision medicine and patient-centered treatments
This is your chance to get direct answers from a leading industry expert. Whether you're a researcher, clinician, or biotech professional, this session will provide exclusive insights into the future of cell and gene therapy.
Clarivate will also be joining us for a featured panel discussion at our Cell and Gene Therapy 2025 online symposium on March 19, where they will provide expert analysis on the Drugs to Watch 2025 report.
Secure your free spot by checking the box when registering for this Ask Me Anything session.
